Laser myocardial revascularization modulates expression of angiogenic, neuronal, and inflammatory cytokines in a porcine model of chronic myocardial ischemia

Journal of Cardiac Surgery

Volumn 17, Issue 5, 2001, Pages 413-424

  Fuchs, Shmuel ^a   Baffour, Richard ^a   Vodovotz, Yoram ^a   Shou, Matie ^a   Stabile, Eugenio ^a   Tio, Fermin O ^b   Leon, Martin B ^c   Kornowski, Ran ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Biomed Res Found of S Texas Inc   (United States)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 8; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR BETA SUBUNIT; SUBSTANCE P; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CYTOKINE PRODUCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HISTOPATHOLOGY; HOLMIUM LASER; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; REGULATORY MECHANISM; SWINE;

EID: 0036771262     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb01171.x     Document Type: Article

References (46)

1. Cooley DA, Frazier OH, Kadipasaoglu KA, et al: Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 1996;111:791-799.
2. Horvath KA, Cohn LH, Cooley DA, et al: Transmyocardial laser revascularization results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997;113:645-654.
3. Milano A, Pratali S, Tartarini G, et al: Early results of transmyocardial revascularization with a Holmium laser. Ann Thorac Surg 1998;65:700-704.
4. Burkhoff D, Schmidt S, Schulman SP, et at: Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet 1999;354:885-890.
5. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999;341:1029-1036.
6. Aaberge L, Nordstrand K, Dragsund M, et al: Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol 2000;35:1170-1177.
7. Lauer B, Junghans U, Stahl F, et al: Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol 1999;34:1663-1670.
8. Lauer B, Stahl F, Junghans U, et al: Long-term results after percutaneous myocardial laser revascularization in patients with end stage coronary artery disease. (Abstract) J Am Coll Cardiol 1999;23(Suppl A):381A.
9. Oesterle SN, Sanborn TA, Ali N, et al: Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000;356:1705-1710.
10. Kornowski R, Baim DS, Moses JW, et al: Acute and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by Biosense™ left ventricular electro- mechanical mapping. Circulation 2000;102:1120-1125.
11. Schofield PM, Sharples LD, Caine N, et al: Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial. Lancet 1999;353:519-524.
12. th Scientific Session, Orlando, FL, March 2001.
13. Kornowski R, Hong MK, Haudenschild C, et al: Feasibility and safety of percutaneous direct myocardial revascularization using Biosense™ system in porcine hearts. Coronary Artery Disease 1998;9:535-540.
14. Yamamoto N, Kohmoto T, Gu A, et al: Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 1998;31:1426-1433.
15. Kwong KF, Kanellopoulos GK, Nickols JC, et al: Transmyocardial laser denervates canine myocardium. J Thorac Cardiovasc Surg 1997;114:883-889.
16. Ben-Haim SA, Osadchy D, Schuster I, et al: Non-fluoroscopic, in vivo navigation and mapping technology. Nature Med 1996;2:1393-1395.
17. Gepstein L, Hayam G, Ben-Haim SA. A novel method for non-fluoroscopic catheter based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation 1997;95:1611-1622.
18. Kornowski R, Hong MK, Gepstein L, et al: Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myovardium. Circulation 1998;98:1116-1124.
19. Fuchs S, Kornowski R, Shiran A, et al: Electromechanical characterization of myocardial hibernation in a pig model. Coronary Artery Disease 1999;3:195-198.
20. Fuchs S, Baffour R, Shou M, et al: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. (Abstract) J Am Coll Cardiol 2000;35(Suppl A):60A.
21. Cercek B, Yamashita M, Dimayuga P, et al: Nuclear factor κB activity and arterial response to balloon injury. Atherosclerosis 1997;13:59-66.
22. Roth DM, Maruoka Y, Rogers J, et al: Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol 1987;253:H1279-1288.
23. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995;76:479-488.
24. Ito WD, Arras M, Winkler B, et al: Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837.
25. Buschmann I, Schaper W: The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 2000;190:338-342.
26. Chu V, Kuang JQ, McGinn A, et al: Angiogenic response induced by mechanical transmyocardial revascularization. J Thorac Cardiovasc Surg 1999;118:849-856.
27. Horvath KA, Chiu E, Maun DC, et al: Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 1999 68):825-829.
28. Fisher PE, Khomoto T, DeRosa CM, et al: Histologic analysis of transmyocardial channels: Comparison of CO2 and holmium:YAG lasers. Ann Thorac Surg 1997;64:466-472.
29. Huang MH, Sylven C, Horackova M, et al: Ventricular sensory neurons in canine dorsal root ganglia: Effects of adenosin and substance P. Am J Physiol 1995;269:R318-324.
30. Raivich G, Kreutzberg GW: Nerve growth factor and regeneration of peripheral nervous system. Clin Neurol Neurosurg 1993;95 Suppl:S84-88.
31. Heumann R, Korsching S, Bandtlow C, et al: Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection. J Cell Biol 1987;104:1623-1631.
32. Gu Y, Yong Q, Yoshida K, et al: Rapid increase in NGF-1 mRNA after ischemia/reperfusion and preconditioning in rat heart. (Abstract) Circulation 1994;(Suppl I):I-249.
33. Abe T, Morgan D, Gutterman DD: Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997;95:213-220.
34. Kaye MP, Wells DJ, Tyce GM.: Nerve growth factor-enhanced reinnervation of surgically denervated canine heart. Am J Physiol 1979;236:H624-628.
35. Lindholm D, Heumann R, Meyer M, et al: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987;330:658-659.
36. Hirsch GM, Thompson GW, Arora RC, et al: Transmyocardial laser revascularization does not denervate the canine heart. Ann Thorac Surg 1999;68:460-468.
37. Al-Sheikh T, Allen KB, Straka SP, et al: Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 1999;100:135-140.
38. Kwong KF, Schuessler RB, Kanellopoulos GK, et al: Nontransmural laser treatment incompletely denervates canine myocardium. Circulation 1998;98(19 Suppl):II67-71.
39. Wang DL, Wung BS, Shyy YJ, et al: Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells. Circ Res 1995;77:294-302.
40. Wemper F, Lindner V, Augustin HG. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol 1997;17:2471-2478.
41. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999;48:1131-1137.
42. Byrd VM, Ballard DW, Miller GG, et al: Fibrobrast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. J Immunol 1999;162:5853-5859.
43. Horvath KA, Smith WJ, Laurence RG, et al: Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 1995;25:258-263.
44. Mack CA, Magovern CJ, Hahn RT, et al: Channel patency and neovascularization after t transmyocardial revascularization using an excimer laser: Results and comparison to nonlased channels. Circulation 1996;(Suppl. II):II-65-II-69.
45. Kohmoto T, Fisher PE, Gu A, et al: Does blood flow through Holmium:YAG transmyocardial laser channels? Ann Thorac Surg 1996;61:861-868.
46. Horvath KA, Chiu E, Maun DC, et al: Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 1999;68:825-829.